CINCINNATI, Oct. 16, 2017 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its fiscal 2018 Revenue and Earnings Guidance before the NASDAQ market opens on Thursday, October 19.